RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Amundi's Holding History (CIK: 0001330387)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 2,401 Value ($000) $12 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 2,273 Value ($000) $17 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 70,775 Value ($000) $456 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 77,686 Value ($000) $571 Avg Close $8.72 Range $6.75 - $10.66
Q1 2024
Shares 71,622 Value ($000) $530 Avg Close $11.14 Range $8.68 - $15.74
Q4 2023
Shares 56,557 Value ($000) $758 Avg Close $7.13 Range $4.97 - $11.17
Q3 2023
Shares 88,562 Value ($000) $565 Avg Close $9.98 Range $6.44 - $16.75
Q2 2023
Shares 55,900 Value ($000) $413 Avg Close $7.00 Range $4.54 - $10.45
Q1 2023
Shares 4,240 Value ($000) $27 Avg Close $7.93 Range $6.40 - $9.73
Q4 2022
Shares 7,189 Value ($000) $57 Avg Close $9.81 Range $7.04 - $13.29
Q3 2022
Shares 4,240 Value ($000) $49 Avg Close $10.13 Range $7.48 - $14.18